State of New Jersey Common Pension Fund D Sells 5,214 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

State of New Jersey Common Pension Fund D trimmed its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBHGet Rating) by 10.8% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 42,994 shares of the company’s stock after selling 5,214 shares during the period. State of New Jersey Common Pension Fund D owned approximately 0.09% of Prestige Consumer Healthcare worth $2,276,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Bank of America Corp DE grew its stake in shares of Prestige Consumer Healthcare by 6.5% in the 4th quarter. Bank of America Corp DE now owns 358,699 shares of the company’s stock valued at $21,754,000 after purchasing an additional 21,826 shares during the period. Cubist Systematic Strategies LLC grew its stake in shares of Prestige Consumer Healthcare by 95.7% in the 4th quarter. Cubist Systematic Strategies LLC now owns 57,520 shares of the company’s stock valued at $3,489,000 after purchasing an additional 28,127 shares during the period. Assenagon Asset Management S.A. bought a new stake in shares of Prestige Consumer Healthcare in the 4th quarter valued at approximately $8,111,000. CWM LLC bought a new stake in shares of Prestige Consumer Healthcare in the 4th quarter valued at approximately $1,930,000. Finally, Nordea Investment Management AB grew its position in Prestige Consumer Healthcare by 3.9% during the 1st quarter. Nordea Investment Management AB now owns 141,625 shares of the company’s stock worth $7,567,000 after acquiring an additional 5,287 shares during the last quarter.

Prestige Consumer Healthcare Stock Down 1.0 %

NYSE:PBH opened at $59.54 on Thursday. The stock’s fifty day moving average price is $57.55 and its two-hundred day moving average price is $56.62. Prestige Consumer Healthcare Inc. has a 52-week low of $51.70 and a 52-week high of $63.83. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.21 and a current ratio of 2.04. The company has a market cap of $2.97 billion, a price-to-earnings ratio of 14.74, a P/E/G ratio of 1.82 and a beta of 0.50.

Prestige Consumer Healthcare (NYSE:PBHGet Rating) last posted its quarterly earnings data on Thursday, May 5th. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.02. The firm had revenue of $266.94 million for the quarter, compared to the consensus estimate of $258.25 million. Prestige Consumer Healthcare had a return on equity of 13.82% and a net margin of 18.90%. The business’s revenue for the quarter was up 12.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.79 EPS. On average, analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.19 EPS for the current year.

Analysts Set New Price Targets

A number of equities research analysts recently commented on PBH shares. Oppenheimer upgraded Prestige Consumer Healthcare from a “market perform” rating to an “outperform” rating and set a $63.00 price target on the stock in a research report on Monday, May 9th. Jefferies Financial Group upgraded Prestige Consumer Healthcare from a “hold” rating to a “buy” rating and increased their price target for the stock from $65.00 to $70.00 in a research report on Tuesday, May 10th. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $80.50.

About Prestige Consumer Healthcare

(Get Rating)

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

Read More

Want to see what other hedge funds are holding PBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Prestige Consumer Healthcare Inc. (NYSE:PBHGet Rating).

Institutional Ownership by Quarter for Prestige Consumer Healthcare (NYSE:PBH)

Want More Great Investing Ideas?

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.